Show simple item record

dc.contributor.authorBradner, James Een_US
dc.date.accessioned2015-02-02T15:32:57Z
dc.date.issued2014en_US
dc.identifier.citationBradner, James E. 2014. “From transcriptional regulation to drugging the cancer epigenome.” Genome Medicine 6 (12): 123. doi:10.1186/s13073-014-0123-1. http://dx.doi.org/10.1186/s13073-014-0123-1.en
dc.identifier.issn1756-994Xen
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:13890713
dc.description.abstractJay Bradner discusses the opportunities and challenges for the study and therapeutic targeting of the cancer epigenome, as well as innovative approaches to drug discovery.en
dc.language.isoen_USen
dc.publisherBioMed Centralen
dc.relation.isversionofdoi:10.1186/s13073-014-0123-1en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295578/pdf/en
dash.licenseLAAen_US
dc.titleFrom transcriptional regulation to drugging the cancer epigenomeen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalGenome Medicineen
dash.depositing.authorBradner, James Een_US
dc.date.available2015-02-02T15:32:57Z
dc.identifier.doi10.1186/s13073-014-0123-1*
dash.contributor.affiliatedBradner, James E


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record